Immunic Inc (NASDAQ: IMUX) kicked off on Friday, down -5.75% from the previous trading day, before settling in for the closing price of $0.87. Over the past 52 weeks, IMUX has traded in a range of $0.56-$2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.01% over the last five years. While this was happening, its average annual earnings per share was recorded 32.33%. With a float of $95.28 million, this company’s outstanding shares have now reached $98.65 million.
Immunic Inc (IMUX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.42%, while institutional ownership is 69.62%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.24 earnings per share (EPS), lower than consensus estimate (set at -0.22) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.07% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Take a look at Immunic Inc’s (IMUX) current performance indicators. Last quarter, stock had a quick ratio of 2.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Analysing the last 5-days average volume posted by the [Immunic Inc, IMUX], we can find that recorded value of 1.24 million was better than the volume posted last year of 1.24 million. As of the previous 9 days, the stock’s Stochastic %D was 7.34%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 34.67%, which indicates a significant increase from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0683 in the past 14 days, which was lower than the 0.0792 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8725, while its 200-day Moving Average is $1.0008. Now, the first resistance to watch is $0.8626. This is followed by the second major resistance level at $0.9052. The third major resistance level sits at $0.9315. If the price goes on to break the first support level at $0.7937, it is likely to go to the next support level at $0.7674. Now, if the price goes above the second support level, the third support stands at $0.7248.
Immunic Inc (NASDAQ: IMUX) Key Stats
The company with the Market Capitalisation of 80.89 million has total of 98,651K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -100,510 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -26,820 K.
